Asia Pacific In-vitro Diagnostics Enzymes Market Size & Outlook
Asia Pacific in-vitro diagnostics enzymes market, 2018-2030 (US$M)
Asia Pacific in-vitro diagnostics enzymes market highlights
- The Asia Pacific in-vitro diagnostics enzymes market generated a revenue of USD 377.1 million in 2024.
- The market is expected to grow at a CAGR of 11.5% from 2025 to 2030.
- In terms of segment, polymerase & transcriptase was the largest revenue generating enzyme in 2024.
- Proteases is the most lucrative enzyme segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2030.
Asia Pacific data book summary
| Market revenue in 2024 | USD 377.1 million |
| Market revenue in 2030 | USD 724.0 million |
| Growth rate | 11.5% (CAGR from 2025 to 2030) |
| Largest segment | Polymerase & transcriptase |
| Fastest growing segment | Proteases |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Proteases, Polymerase & Transcriptase, Ribonuclease |
| Key market players worldwide | Biocatalysts Ltd, Merck KGaA, Codexis Inc, Roche Holding AG, Amano Enzyme, Advanced Enzymes, Amicogen, Dyadic International Inc, BBI Solutions, Affymetrix, American Laboratories, Inc. |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 22.1% of the global in-vitro diagnostics enzymes market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 724.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In-vitro Diagnostics Enzymes Market Scope
In-vitro Diagnostics Enzymes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific in-vitro diagnostics enzymes market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in-vitro diagnostics enzymes market will help companies and investors design strategic landscapes.
Polymerase & transcriptase was the largest segment with a revenue share of 43.17% in 2024. Horizon Databook has segmented the Asia Pacific in-vitro diagnostics enzymes market based on proteases, polymerase & transcriptase, ribonuclease covering the revenue growth of each sub-segment from 2018 to 2030.
Presence of huge target population, improvements in healthcare infrastructure, and high unmet clinical needs, increase in government initiatives, rise in R&D activities for advanced diagnostic techniques, and increased healthcare expenditure are some factors anticipated to create growth opportunities for key manufacturers in this region.
In addition, growing prevalence of infectious diseases such as HIV/AIDS, hepatitis, and immune system disorders is anticipated to boost the demand for IVDs during the forecast period. Continuously decreasing cost of sequencing and DNA manipulation acts as a demand driver for the increase in the adoption of enzymes for diagnostic, biotechnology, & research use.
Reasons to subscribe to Asia Pacific in-vitro diagnostics enzymes market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific in-vitro diagnostics enzymes market databook
-
Our clientele includes a mix of in-vitro diagnostics enzymes market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific in-vitro diagnostics enzymes market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific in-vitro diagnostics enzymes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific in vitro diagnostics enzymes market size, by country, 2018-2030 (US$M)
Asia Pacific In-vitro Diagnostics Enzymes Market Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
